Johnson & Johnson has reported three-year clinical remission data for [...]

ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

MaaT Pharma plans to advance a global Phase 3 trial [...]

The FDA has accepted Belite Bio’s application for tinlarebant and [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

The FDA has approved Moderna’s mRNA seasonal influenza vaccine mFLUSIVA [...]

Vaderis Therapeutics has raised $152M and started a global Phase [...]

The EMA’s CHMP has recommended EU approval of Lynavoy for [...]

The EMA’s CHMP has recommended approval of NEZGLYAL for boys [...]

Atsena Therapeutics has received EMA orphan designation for two gene [...]